SpyBiotech: Funding, Investors & Team (Oct 2026)
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines which give better results in lesser time.
SpyBiotech has raised $32.5M across 1 funding round on record, the most recent a Series A of $32.5M announced in Feb 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SpyBiotech Company Profile and Key Stats
Latest funding round on record: Feb 2021.
SpyBiotech Funding Rounds
SpyBiotech Founders and Leadership Team
Contact details for the SpyBiotech team: 1 of 1 has an email address on file.
Start 14-day free trial →SpyBiotech Funding Compared to Other Biotechnology Startups
SpyBiotech's latest round of $32.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SpyBiotech in Biotechnology and Oxford
Companies Similar to SpyBiotech
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
SpyBiotech Funding FAQs
What does SpyBiotech do?
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines which give better results in lesser time.
How much funding has SpyBiotech raised?
SpyBiotech has raised $32.5M across 1 round on record. The most recent is a Series A of $32.5M announced in Feb 2021.
When did SpyBiotech last raise funding?
SpyBiotech's most recent funding round on record is a Series A of $32.5M, announced in Feb 2021.
Who is the CEO of SpyBiotech?
Sumi Biswas is listed as CEO at SpyBiotech.
Where is SpyBiotech headquartered?
SpyBiotech is based in Oxford, Oxfordshire, United Kingdom.
How many employees does SpyBiotech have?
SpyBiotech is in the 1-10 employee band.
How does SpyBiotech's funding compare to other Biotechnology startups?
SpyBiotech's latest round of $32.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SpyBiotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SpyBiotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.